Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-02-03 10:44 am Unchanged |
2022-12-31 | 13G | Gene Biotherapeutics, Inc. CRXM |
Jemapete Christopher J | 4,000,000 6.200% |
0 (Unchanged) |
Filing History |
| 2023-02-03 10:33 am Sale |
2022-12-31 | 13G | Blue Biofuels, Inc. BIOF |
Jemapete Christopher J | 2,600,000 0.900% |
-9,075,000 (-77.73%) |
Filing History |
| 2022-01-24 5:23 pm Purchase |
2021-12-31 | 13G | Blue Biofuels, Inc. BIOF |
Jemapete Christopher J | 11,675,000 4.300% |
11,675,000 (New Position) |
Filing History |
| 2021-04-28 4:20 pm Unchanged |
2021-03-31 | 13G | Gene Biotherapeutics, Inc. CRXM |
Jemapete Christopher J | 4,000,000 8.100% |
0 (Unchanged) |
Filing History |
| 2021-03-18 2:05 pm Purchase |
2021-03-16 | 13D | Gene Biotherapeutics, Inc. CRXM |
Jemapete Christopher J | 4,000,000 27.600% |
500,000 (+14.29%) |
Filing History |
| 2021-03-05 08:00 am Sale |
2021-03-05 | 13G | ALLIANCE BIOENEGY PLUS INC ALLM |
Jemapete Christopher J | 12,275,000 5.100% |
-2,225,000 (-15.34%) |
Filing History |
| 2021-03-01 4:48 pm Purchase |
2021-02-25 | 13D | Gene Biotherapeutics, Inc. CRXM |
Jemapete Christopher J | 3,500,000 24.200% |
3,500,000 (New Position) |
Filing History |